CLINICAL_TRIALS
trial_result
· 2013-11-19
Clinical Trial Update: Exacerbation Study [Phase 3]
Summary
Novartis completed a Phase 3 exacerbation study in chronic obstructive pulmonary disease and posted the results. The specific drug name is not provided in the s…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: COMPLETED | Results posted: 2013-11-19